Home
About
FAQ
History (8)
Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis.
Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.
Societies
Effects of phenylarsine oxide on expression of heme oxygenase-1 reporter constructs in transiently transfected cultures of chick embryo liver cells.
Iron as a co-morbid factor in nonhemochromatotic liver disease.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Iron as a co-morbid factor in nonhemochromatotic liver disease.
Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol. 2003 Jun; 30(2):137-44.
View in:
PubMed
subject areas
Fatty Liver
Hepatitis C, Chronic
Histocompatibility Antigens Class I
Humans
Iron
Iron Overload
Liver
Liver Diseases
Liver Diseases, Alcoholic
Membrane Proteins
Mutation
Porphyria Cutanea Tarda
Portasystemic Shunt, Surgical
Risk Factors
authors with profiles
Herbert L. Bonkovsky MD